GNPX

Genprex, Inc. is a pioneering clinical-stage gene therapy company based in Austin, Texas, focused on redefining treatment paradigms for cancer and diabetes through its proprietary gene therapy platforms. With a robust pipeline driven by extensive clinical trials, Genprex addresses critical unmet needs in oncology and metabolic diseases, aiming to improve patient health outcomes. The company is strategically positioned to become a leader in the gene therapy domain, leveraging its innovative research to potentially deliver groundbreaking medical solutions that could significantly enhance the quality of life for patients worldwide.